Tag: Novozymes


A previous post discussed the dismissal of Danisco‘s declaratory judgment action against its rival Novozymes.  As described by the San Francisco district court decision, the Danish companies are “reputedly the two major competitors in the field of developing and supplying industrial enzymes Read more…


Previous posts, e.g., here and here, discussed the patent infringement litigation between Danish biopharm rivals Novozymes and Danisco (now owned by DuPont), which are both active in developing enzymes used in the production of biofuels. In the suit, Novozymes accused Read more…


A previous post reported on a declaratory judgment action brought by DuPont-owned biopharmaceutical company Danisco against Novozymes. The two companies are both Danish and appear to be arch rivals. As the court described it, they are “reputedly the two major Read more…


In previous posts I discussed the patent infringement suit brought by Danish biotech Novozymes against its rival Danisco (recently acquired by DuPont). Specifically, Novozymes sued Danisco in May 2010 in the Western District of Wisconsin, alleging infringement of U.S. Patent Read more…


In a previous post, I wrote about a patent infringement suit between Danish biopharm rivals Novozymes and Danisco, which are both active in developing enzymes used in production of biofuels. In the suit, Novozymes has accused Danisco of infringing U.S. Read more…


Just over a week ago, Denmark became the first European country to make available to drivers second generation biofuel, fuel made of agricultural residues that do not compete with food crops. The fuel, called Bio95, is now on offer at Read more…

Skip to toolbar